Live Breaking News & Updates on Sinopharm China National Pharmaceutical Group Co Ltd

Stay updated with breaking news from Sinopharm china national pharmaceutical group co ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Immunised Laotians offer reassurance over Chinese Covid-19 vaccine safety


Chanthasouk Syvongsa, a resident of Lao capital Vientiane, just received two doses of Sinopharm vaccines.
I had my first injection on March 26 at the 103 Hospital and, like everyone else, was required to wait for 20-30 minutes to see if there were side effects or allergies, he said.
Afterwards I felt sleepy for a little while but the next day I felt fine and was able to do everything I normally do, except that I wasn t supposed to drink alcohol for seven days.
He had the second injection on April 23.
I felt a bit sore around the injection site but when I woke up the next morning I was back to normal, except that again I had to wait seven days before drinking any alcohol, Chanthasouk said. ....

Souphatta Vongkhammany , Phankham Viphavanh , Chanthasouk Syvongsa , Wattay International Airport , Sinopharm China National Pharmaceutical Group Co Ltd , Vientiane Times Asia News Network , Some Lao , Lao Prime Minister Phankham Viphavanh , Asia News , Covid 19 , வியெந்ஶேந் முறை ஆசியா செய்தி வலைப்பின்னல் , ஆசியா செய்தி ,

Laos to begin second round of Covid-19 vaccinations this month


VIENTIANE (Vientiane Times/ANN): Some 150,000 medical workers around the country will be vaccinated against Covid-19 this month and next following China’s donation of 300,000 doses of vaccine.
The vaccine was developed by Sinopharm (China National Pharmaceutical Group Co, Ltd), which previously provided 2,000 doses to Laos.
People in at-risk groups between the ages of 18 and 60 will also be given priority in receiving vaccinations. They include medical staff, elderly people, those with a chronic illness, and migrant workers.
Medical workers and staff continue to face challenges in monitoring people at border crossings and providing assistance to returning workers affected by the pandemic. ....

Phonepaseuth Ounaphom , Health Promotion , National Taskforce Committee For Covid , Department Of Hygiene , Ministry Of Health , United Nations , Sinopharm China National Pharmaceutical Group Co Ltd , National Taskforce Committee , Gavi Covax Facility , Gavi Covax , Covid 19 , Second Round , ஆரோக்கியம் ப்ரமோஶந் , துறை ஆஃப் சுகாதாரம் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , ஒன்றுபட்டது நாடுகள் , இரண்டாவது சுற்று ,

More people to be inoculated next week


THE next target group of frontline medical staff is scheduled to be vaccinated against Covid-19 next week after more than 100 people vaccinated earlier showed no side effects.
The vaccine, which was first administered in late November, produced good results, Deputy Minister of Health, Assoc Prof Dr Phouthone Muongpak, said on Tuesday.
People need two doses to develop immunity to Covid-19.
The first group of frontline officials including medical staff had their first vaccinations in late November and the second on Dec 22.
“There were no side effects or problematic symptoms, ” said Dr Phouthone, who is Deputy Head of the National Taskforce for Covid-19 Prevention and Control. ....

Phouthone Muongpak , Russia Gamaleya Research Institute , Health Assoc Prof Dr Bounkong Syhavong , Sinopharm China National Pharmaceutical Group Co Ltd , World Health Organisation , Deputy Minister , Assoc Prof Dr Phouthone Muongpak , Deputy Head , National Task Force , China National Pharmaceutical Group Co Ltd , Gamaleya Research , Gavi Covax Facility , Covax Facility , Emergency Use Listing , Front Line , Covid 19 , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , துணை அமைச்சர் , துணை தலை , தேசிய பணி படை , சீனா தேசிய மருந்து குழு இணை லிமிடெட் , அவசரம் பயன்பாடு பட்டியல் , முன் வரி ,

Laos declares Covid-19 vaccinations safe, more to be inoculated next week


VIENTIANE (Vientiane Times/ANN): The next target group of frontline medical staff is scheduled to be vaccinated against Covid-19 next week after more than 100 people vaccinated earlier showed no side effects.
The vaccine, which was first administered in late November, produced good results, Deputy Minister of Health, Associate Prof Dr Phouthone Muongpak, told a press conference on Tuesday (Jan 5).
People need two doses of the vaccine to develop immunity to Covid-19.
The first group of frontline officials including medical staff had their first vaccination in late November and the second on Dec 22.
“There were no side effects or problematic symptoms, ” said Dr Phouthone, who is Deputy Head of the National Taskforce for Covid-19 Prevention and Control. ....

Phouthone Muongpak , Bounkong Syhavong , Russia Gamaleya Research Institute , World Health Organization , Health Associate Prof , Sinopharm China National Pharmaceutical Group Co Ltd , Deputy Minister , Associate Prof Dr Phouthone Muongpak , Deputy Head , National Task Force , Gamaleya Research , Gavi Covax Facility , Health Associate , Covax Facility , Emergency Use Listing , Covid 19 , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஆரோக்கியம் இணை ப்ரொஃப் , துணை அமைச்சர் , துணை தலை , தேசிய பணி படை , ஆரோக்கியம் இணை , அவசரம் பயன்பாடு பட்டியல் ,